Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Selective inhibitor of JAK1 and JAK2 kinases including the JAK2 V617F mutant
ENZ-CHM197-0001 1 mg 55.00 USD
ENZ-CHM197-0005 5 mg 105.00 USD
Do you need bulk/larger quantities?
Using ATP kinase assays, the IC50 values for CYT387 are a follows - JAK1 (11nM), JAK2, (18nM), JAK2 V617F (23nM) JAK3 (155nM), and TYK2 (17nM). In testing kinase arrays, CYT387 also had activity (defined as an IC50 < 100nM) detected against CDK2/cyclin A, MAPK8 (JNK1), PRKCN (PKD3), PRKD1 (PKCμ), ROCK2, and TBK1 kinase as well.

Product Specification

Alternative Name:CYT 387, N-​​(cyanomethyl)​-​​4-​​[2-​​[[4-​​(4-​​morpholinyl)​phenyl]​amino]​-​​4-​​pyrimidinyl]​-​benzamide
Purity:≥97% (HPLC)
Identity:Determined by NMR.
Appearance:Yellow to orange powder.
Solubility:Soluble in DMSO (>20mM).
Short Term Storage:+4°C
Long Term Storage:-20°C
Regulatory Status:RUO - Research Use Only
ENZ-CHM197 structure
Please mouse over
ENZ-CHM197 structure

Related Literature

Integrated solutions for screening Wnt regulators
Integrated solutions for screening Wnt regulators
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2020 Enzo Life Sciences, Inc.,